So many ‘ifs’. However, if they get through cl

So many ‘ifs’. However, if they get through clinical trials and the fda gives them emergency use authorization, I can see the pps skyrocketing given the nearly global distribution network they’ve set up. Initial and or booster in the US, Canada, Europe, and initial vaccination in Africa, Asia, the Middle East. I wouldn’t even hazard a guess on pps by summer. But that’s a lot of initial ‘ifs’.